Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
Pre-Market
In 30 days
Novo Nordisk is a leading global pharmaceutical company from Denmark, focusing on developing innovative therapies. Its primary areas of expertise are diabetes and obesity, while rare blood disorders and hormone-related conditions are also core business segments. The company is dedicated to improving patient health and quality of life worldwide through advanced medicines.